Purification and characterization of lupus anticoagulant like protein from Agkistrodon halys brevicaudus venom.
By means of CM-Sephadex C-25, DEAE-Sephadex A-50, Sephadex G-200, and Sephadex G-75 chromatographies, a lupus anticoagulant like protein (LALP) from Agkistrodon halys brevicaudus was purified. On SDS-PAGE, the purified LALP had a molecular weight of 25,500 daltons under non-reducing condition and 15,000 daltons under reducing condition. The isoelectric point was pH 5.6. Its N terminal amino acid sequencing revealed a mixture of 2 sequences: DCP(P/S)(D/G)WSSYEGH(C/R)(Q/K). It was devoid of phospholipase A, fibrino(geno)lytic, 5'-nucleotidase, L-amino acid oxidase, phosphomonoesterase, phosphodiesterase and thrombin-like activities, which were found in crude venom. In the presence of LALP, PT, aPTT, and dRVVT of human plasma were markedly prolonged and its effects were concentration-dependent but time-independent. The inhibitory effect of LALP on the plasma clotting time was enhanced by decreasing phospholipid concentration in TTI test. The individual clotting factor activity was not affected by LALP when higher dilutions of LALP-plasma mixture were used for assay. Russell's viper venom time was shortened when high phospholipid confirmatory reagent was used. Therefore, the protein has lupus anticoagulant property.
Li
Z Y
ZY
Hemophilia and Thrombosis Center/Sylvester Cancer Center, University of Miami, FL, USA.
Wu
X W
XW
Yu
T F
TF
Lian
E C
EC
D017836:Agkistrodon; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D002845:Chromatography; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000302:isolation & purification* / Q000378:metabolism / Q000494:pharmacology; D011517:Prothrombin Time; D014688:Venoms / Q000378:metabolism*
D016682:Lupus Coagulation Inhibitor; D014688:Venoms